Edition:
India

People: AtriCure Inc (ATRC.OQ)

ATRC.OQ on NASDAQ Stock Exchange Global Market

28.17USD
1:30am IST
Change (% chg)

$0.21 (+0.75%)
Prev Close
$27.96
Open
$27.95
Day's High
$28.39
Day's Low
$27.60
Volume
67,095
Avg. Vol
84,323
52-wk High
$36.08
52-wk Low
$19.77

Groves, Regina 

Ms. Regina E. Groves is Independent Director of the AtriCure Inc. Ms. Groves has been the Chief Executive Officer at REVA Medical, Inc. since September 2015. In 2017 Prior to her current position, Ms. Groves served as Vice President and General Manager of the AF Solutions, Cardiac Rhythm and Heart Failure division of Medtronic, Inc., a leading global medical technology company. In this position, she successfully developed and executed strategies to re-enter the catheter-based Afib ablation market and achieved the goal to be market leader in paroxysmal, or intermittent, Afib ablation. The role also allowed her to successfully acquire and integrate companies, complete numerous clinical trials and launch novel products in the United States and worldwide. Prior to this, she was the Vice President of Quality and Regulatory for Medtronic’s Cardiac Rhythm Disease Management (CRDM) business from 2006 to 2008 and before that was Vice President and General Manager for Patient Management CRDM at Medtronic from 2002 to 2006. Ms. Groves holds a B.S. in Pharmacy from the University of Florida and an M.B.A. from Harvard Graduate School of Business Administration.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Award, USD 174,987
Long-Term Incentive Plans, USD --
All Other, USD 43,561
Fiscal Year Total, USD 218,548

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Scott Drake

194,982

Michael Carrel

4,156,350

M. Andrew Wade

1,075,720

Douglas Seith

1,841,050

Justin Noznesky

1,023,000

Salvatore Privitera

1,624,280
As Of  31 Dec 2017